Brief: Anteris Technologies Announces Issuance Of Utility Patent For Novel Duravr Transcatheter Heart Valve
12/04/2023 02:20
April 12 (Reuters) - Anteris Technologies Ltd AVR.AX :
* UNITED STATES PATENT AND TRADEMARK OFFICE ISSUED UTILITY
PATENT
FOR NOVEL DURAVR TRANSCATHETER HEART VALVE
Source text for Eikon: ID:nASX5lZC9l
Further company coverage: AVR.AX
Recent news on Anteris Technologies
See all newsBrief: Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial
Anteris Technologies up as brokerages initiate coverage post-research quiet period
Brief: Anteris Technologies Says Aggregate Gross Proceeds From Offering Was $88.8 Mln
Anteris Technologies slides in Nasdaq debut after $89 mln US IPO
Brief: Anteris Technologies Prices 14.8 Mln Shares At $6.00 Per Share for U.S. IPO